Literature DB >> 9405400

MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases.

S Xu1, M H Cobb.   

Abstract

Mitogen-activated protein (MAP) kinases mediate responses to a wide array of cellular stimuli. These cascades consist of a MAP kinase or extracellular signal-regulated kinase (ERK), activated by a MAP/ERK kinase (MEK), in turn activated by a MEK kinase (MEKK). MEKK1 has been shown to be a strong activator of the c-Jun N-terminal kinase/stress-actived protein kinase (JNK/SAPK) pathway. We report here that JNK/SAPK binds directly to the N-terminal, noncatalytic domain of MEKK1 in vitro and in transfected cells. Immobilized MEKK1-derived peptides extract JNK/SAPK selectively from cell lysates. MEKK1 coimmunoprecipitates with multiple JNK/SAPK isoforms in transfected cells. Expression of the N terminus of MEKK1 lacking the kinase domain increases activation of endogenous JNK/SAPK by MEKK1. The data are consistent with a model in which MEKK1-JNK/SAPK binding facilitates the receipt of signals from upstream inputs and localizes JNK/SAPK to intracellular targets of the pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405400     DOI: 10.1074/jbc.272.51.32056

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Insulin inhibits glucocorticoid-stimulated L-type 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene expression by activation of the c-Jun N-terminal kinase pathway.

Authors:  M Joaquin; A Tauler
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties.

Authors:  A Levchenko; J Bruck; P W Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.

Authors:  Yuri V Fedorov; Nathan C Jones; Bradley B Olwin
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.

Authors:  Yafei Li; Zhifu Sun; Julie M Cunningham; Marie C Aubry; Jason A Wampfler; Gary A Croghan; Cassandra Johnson; Danli Wu; Jeremiah A Aakre; Julian Molina; Liewei Wang; V Shane Pankratz; Ping Yang
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

5.  Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms.

Authors:  L Butterfield; E Zentrich; A Beekman; L E Heasley
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

6.  MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells.

Authors:  Maoxian Deng; Wei Ding; Xuewen Min; Ying Xia
Journal:  Cytoskeleton (Hoboken)       Date:  2010-08-18

7.  Construction of a genetic multiplexer to toggle between chemosensory pathways in Escherichia coli.

Authors:  Tae Seok Moon; Elizabeth J Clarke; Eli S Groban; Alvin Tamsir; Ryan M Clark; Matthew Eames; Tanja Kortemme; Christopher A Voigt
Journal:  J Mol Biol       Date:  2010-12-23       Impact factor: 5.469

Review 8.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 9.  The role of scaffold proteins in JNK signalling.

Authors:  W Engström; A Ward; K Moorwood
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

10.  The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.